Semaglutide: Uses, Dosage, and Side Effects Semaglutide is a GLP-1 receptor agonist prescribed for managing type 2 diabetes and, under the brand name Wegovy, for chronic weight management in individuals with obesity or overweight conditions accompanied by weight-related health issues
Biomarker assessmentincluding inflammatory markers, metabolic syndrome criteria, and fasting insulin levelscan help provide context for which dual or single GLP-1 strategy may better align with your metabolic state
The intake is an asynchronous health questionnaire under five minutes long, and the provider reviews it inside the portal
Women often use slightly lower doses (200-400mcg total) and may experience excellent results for body composition, skin quality, and anti-aging benefits
HanyudaAKimSAMartinez-FernandezAQianZRYamauchiMNishiharaRet al